Alzheimer's disease Archimedes condition-event simulator: Development and validation

por Kansal, Anuraag R., Tafazzoli, Ali, Ishak, K. Jack, Krotneva, Stanmira
Publicado 2018

Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses

por Grabowski, David C., Kansal, Anuraag R., Goldman, Dana P., Lakdawalla, Darius N.
Publicado 2023

A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation

por Sorensen, Sonja V., Peng, Siyang, Monz, Brigitta U., Bradley-Kennedy, Carole, Kansal, Anuraag R.
Publicado 2013

Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK

por Hackshaw, Allan, Cohen, Sarah S., Reichert, Heidi, Kansal, Anuraag R., Chung, Karen C., Ofman, Joshua J.
Publicado 2021

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States

por Kansal, Anuraag R., Cowie, Martin R., Kielhorn, Adrian, Krotneva, Stanimira, Tafazzoli, Ali, Zheng, Ying, Yurgin, Nicole
Publicado 2016

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

por Kansal, Anuraag R, Sorensen, Sonja V, Gani, Ray, Robinson, Paul, Pan, Feng, Plumb, Jonathan M, Cowie, Martin R
Publicado 2012

Health state utility values by cancer stage: a systematic literature review

por Pourrahmat, Mir-Masoud, Kim, Ashley, Kansal, Anuraag R., Hux, Marg, Pushkarna, Divya, Fazeli, Mir Sohail, Chung, Karen C.
Publicado 2021

Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests

por Gelhorn, Heather, Ross, Melissa M., Kansal, Anuraag R., Fung, Eric T., Seiden, Michael V., Krucien, Nicolas, Chung, Karen C.
Publicado 2022

Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease

por Reifsnider, Odette S, Kansal, Anuraag R, Gandhi, Pranav K, Cragin, Lael, Brand, Sarah B, Pfarr, Egon, Fahrbach, Kyle, Ustyugova, Anastasia
Publicado 2021

The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA

por Tafazzoli, Ali, Ramsey, Scott D., Shaul, Alissa, Chavan, Ameya, Ye, Weicheng, Kansal, Anuraag R., Ofman, Josh, Fendrick, A. Mark
Publicado 2022

Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia

por Kansal, Anuraag R., Reifsnider, Odette S., Brand, Sarah B., Hawkins, Neil, Coughlan, Anna, Li, Shujun, Cragin, Lael, Paramore, Clark, Dietz, Andrew C., Caro, J. Jaime
Publicado 2021

Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States

por Borer, Jeffrey S., Kansal, Anuraag R., Dorman, Emily D., Krotneva, Stanimira, Zheng, Ying, Patel, Harshali K., Tavazzi, Luigi, Komajda, Michel, Ford, Ian, Böhm, Michael, Kielhorn, Adrian
Publicado 2016

Cost‐effectiveness of empagliflozin in the UK in an EMPA‐REG OUTCOME subgroup with type 2 diabetes and heart failure

por Reifsnider, Odette S., Kansal, Anuraag R., Franke, Jennifer, Lee, Joseph, George, Jyothis T., Brueckmann, Martina, Kaspers, Stefan, Brand, Sarah B., Ustyugova, Anastasia, Linden, Stephan, Stargardter, Matthew, Hau, Nikco
Publicado 2020

Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database

por Hummel, James P., Leipold, Robert J., Amorosi, Stacey L., Bao, Haikun, Deger, Kristen A., Jones, Paul W., Kansal, Anuraag R., Ott, Lesli S., Stern, Sean, Stein, Kenneth, Curtis, Jeptha P., Akar, Joseph G.
Publicado 2019